Disclaimer

IMPORTANT  NOTICE

The information contained in this section of the BTG website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia, collectively the "United States"), Australia, Canada, Japan or South Africa or any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

The information to which this gatepost gives access is exclusively intended for persons who are not residents of, and who are not physically present in, the United States, Australia, Canada, Japan or South Africa.  This information does not constitute or form a part of an offer to sell or issue, or the solicitation of an offer to purchase, subscribe for or otherwise acquire any securities of BTG plc (the "Company") in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation.  Potential users of this information are requested to inform themselves about and to observe any such restrictions.

None of the documents or other information contained on these pages is an offer of securities for sale in the United States.  The securities referred to on these pages (the "Securities") to be issued by the Company in connection with the placing referred to on these pages (the"Placing") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States.  The Securities may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.  There will be no public offer of the Securities in the United States or elsewhere.  The Securities have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission in the United States or any other US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the placing of the Securities or the accuracy or adequacy of any of the documents or other information contained on these pages.  Any representation to the contrary is a criminal offence in the United States.

Deutsche Bank AG is authorised under German Banking Law (competent authority: BaFin – Federal Financial Supervisory Authority) and authorised and subject to limited regulation by the Financial Conduct Authority in the United Kingdom.  Details about the extent of Deutsche Bank AG's authorisation and regulation by the Financial Conduct Authority are available on request.  J.P. Morgan Securities plc is authorised and regulated by the Financial Conduct Authority in the United Kingdom.  Deutsche Bank AG, London Branch and J.P. Morgan Securities plc and are each acting solely for the Company and no one else in connection with the Placing and they will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients nor for providing advice in relation to the Placing and/or any other matter referred to in this section of the website.  Apart from the responsibilities and liabilities, if any, which may be imposed on Deutsche Bank AG, London Branch and J.P. Morgan Securities plc by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Deutsche Bank AG, London Branch nor J.P. Morgan Securities plc nor any of their respective affiliates accepts any responsibility whatsoever for the contents of the documents or other information contained on these pages or for any other statement made or purported to be made by or on behalf of Deutsche Bank AG, London Branch or J.P. Morgan Securities plc or any of their respective affiliates in connection with the Company, the Securities or the Placing.  Deutsche Bank AG, London Branch and J.P. Morgan Securities plc and each of their respective affiliates accordingly disclaim all and any liability whether arising in tort, contract or otherwise (save as referred to above) in respect of any documents, statements or other information contained on these pages and no representation or warranty, express or implied, is made by Deutsche Bank AG, London Branch or J.P. Morgan Securities plc or any of their respective affiliates as to the accuracy, completeness or sufficiency of the documents or other information contained on these pages.

The release, publication or distribution of the documents or other information contained on these pages may be restricted by law in certain jurisdictions.  Persons into whose possession any of the documents or other information contained on these pages come should inform themselves about and observe any such restrictions.  Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdiction.

Documents or other information contained on these pages, including those related to the Placing, include statements that are, or may be deemed to be, "forward-looking statements".  These forward-looking statements, which may use words such as "aim", "anticipates", "believe", "intend", "estimate", "expect" and words of similar meaning, include all matters that are not historical facts.  These forward-looking statements involve risks and uncertainties that could cause the actual results of operations, financial condition, liquidity, dividend policy and the development of the industries in which the Company's businesses operate to differ materially from the impression created by the forward-looking statements.  These forward-looking statements speak only as at the date of the document or other information concerned.  In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements may not occur.  Other than in accordance with its legal or regulatory obligations (including under the Listing Rules, the Prospectus Rules and the Disclosure and Transparency Rules), neither the Company nor any other person undertakes any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

Information in any of the documents or other information contained on these pages of the price at which the Company's securities have been bought or sold in the past and/or the yield on those securities cannot be relied upon as a guide to future performance.  Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser.

The information contained on these pages is only addressed to and directed at persons in member states of the European Economic Area (“Member States”) who are “qualified investors” within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC), as amended by Directive 2010/73/EU, and related implementation measures in Member States (“Qualified Investors”).  In addition, in the United Kingdom, the information contained on these pages is directed only at Qualified Investors who are: (i) persons who have professional experience in matters relating to investments falling within Articles 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005, as amended (the“Order”); and/or (ii) high net worth entities falling within Article 49 of the Order, and other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons).  The information contained on these pages must not be acted or relied on: (A) in the United Kingdom, by persons who are not relevant persons; and (B) in any Member State other than the United Kingdom, by persons who are not Qualified Investors.  Any investment or investment activity to which the information contained on these pages relates is available only to: (I) in the United Kingdom, relevant persons; and (II) in any Member States other than the United Kingdom, Qualified Investors, and will only be engaged in with such persons.  There will be no public offer of the securities referred to on these pages in any Member State or elsewhere.

By proceeding to view the materials to which this gatepost gives access, you warrant that you have read and understand the statements above, are not located in the United States, Australia, Canada, Japan or South Africa and agree that you will not transmit or otherwise send any information contained in this website to any person in the United States, Australia, Canada, Japan or South Africa or to publications with a general circulation in the United States.  You also warrant that, if you are in the United Kingdom, you are a relevant person and that, if you are in any other Member State apart from the United Kingdom, you are a Qualified Investor.

BTG plc: Results of Placing

23 May 2013

Acquisitions of TheraSphere® and EKOS Corporation and share placing.

The information contained in this section of the BTG plc website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Japan or South Africa or any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

23 May 2013 BTG plc: Proposed Placing of Ordinary New Shares (PDF - 332KB)

23 May 2013 BTG plc: Acquisition of EKOS Corporation (PDF - 329KB)

23 May 2013 BTG plc: Proposed Acquisition of TheraSphere® (PDF - 329KB)

23 May 2013 Investor Presentation - Proposed Acquisitions of TheraSphere® and EKOS Corporation and Share Placing (PDF - 518KB)

23 May 2013 BTG plc: Results of Placing (PDF - 156KB)

21 June 2013 BTG plc: Publication of Circular and Notice of General Meeting

21 June 2013 BTG plc: Proposed Acquisition of the Targeted Therapies Division of Nordion Inc. Circular to Shareholders and Notice of General Meeting

8 July 2013 BTG plc: Completion of Acquisition of EKOS Corporation

11 July 2013 BTG plc: Results of General Meeting - Acquisition of Theraphere®

15 July 2013 BTG plc: Completion of the Acqusition of TheraSphere®